Transcript C-44_Bhat - Advocate Health Care

Motivation and Health Related Quality of Life in Patients
With Left Ventricular Assist Device Implantation for Destination Therapy
C. Gallagher BSN, L.Coyle APN, A. Tatooles, MD, R. Stout, PhD, M. Gavaria, MD, P. Pappas, MD,G. Bhat PhD, MD
Advocate Christ Medical Center, Oak Lawn, Illinois
Introduction
Hypotheses
Patients treated with LVAD for Destination Therapy
have improved HRQOL scores post implant and these
findings would be similar data for the general population.
90
Results
*
80
*
*
*
70
Mean SF-36 Scores
Assessing motivation and psychosocial well being in
patients with Left Ventricular Assist Devices (LVAD) for
destination is integral in the success of the evaluation
of this growing population. The purpose of this study
was to evaluate patient’s motivation for initial implant
and perceived health related quality of life (HRQOL)
post implantation.
Methods
60
Post-Implant
50
U.S. Natl. Norms,
ages 55-64
40
30
Paired sample t-tests of MLWHFQ revealed significantly
improved overall (p < .001) in both the physical (p < .001),
and emotional (p < .001) domain post implant compared to
pre –implant. The subset of patients who completed SF-36
QOL survey had equivalent or better scores compared to
age-matched norms on all subscales of the SF-36 which
included physical functioning (PF), role limitation due to
physical function (RLPF), role limitation due to emotional
problems (RLEP), emotional well being (EWB), social
functioning (SF), general health (GH), and bodily pain (BP).
The primary motivation for LVAD was desire to live longer
while family, religion and severity of illness played a role.
20
10
* =p < .05
Conclusions
0
PF
RLPF
RLEP
E/F EWB
SF-36 Subscales
SF
GH
BP
Conclusion
All patients (n=52) implanted with LVAD for Destination
Therapy between 2005-2007 at our institution completed
Minnesota Living with Heart Failure Questionnaire (MLWHF)
pre and post implant. Of these 52 patients, 21% (n=11) also
completed the Rand Short-Form 36 (SF-36) survey and
interviewed regarding motivation for implant at an average of
17 months (1-33) post hospital discharge.
All patients treated with LVAD reported improved QOL scores
according to the MLWHFQ. SF-36 health survey scores
suggested an increase in HRQOL for patients with a LVAD
compared to the age matched U.S. general population.
Patients primary motivation for LVAD for DT was to live
longer. This study provides a framework to assess reliable
and valid information about functional health and well being
from LVAD patients’ point of view.